Eka Ventures Brings AUM to $200m with Sophomore Health, Wellbeing and Sustainability VC Fund Close

Why It Matters

The infusion of over $100 million positions Eka to accelerate a wave of mission‑aligned startups, potentially reshaping the UK’s health and climate innovation landscape. It also signals that impact investing is becoming mainstream capital for early‑stage ventures.

Key Takeaways

• Eka Ventures' second fund closed at £80m (~$102m)
• Total assets under management now reach $200m
• Fund targets early-stage startups in health, wellbeing, sustainability
• Largest UK impact VC focused on these sectors
• Capital will support climate‑tech, digital health, and wellness innovations

Pulse Analysis

Impact‑focused venture capital has moved from niche to mainstream, and Eka Ventures exemplifies that shift. After a successful first fund, the firm leveraged strong LP interest to raise a second £80 million round, roughly $102 million, propelling its AUM to $200 million. This scale not only validates the appetite for purpose‑driven capital but also gives Eka the bandwidth to source, diligence, and support a broader pipeline of early‑stage companies tackling pressing societal challenges.

The new fund zeroes in on three intersecting megatrends: health, wellbeing and sustainability. Digital health platforms are experiencing a compound annual growth rate exceeding 20 percent as consumers demand remote care and data‑driven insights. Simultaneously, climate‑tech and sustainable consumer products are attracting record venture inflows, driven by regulatory pressure and shifting consumer values. By concentrating on these sectors, Eka positions itself at the nexus of high‑growth markets and measurable impact, offering portfolio companies both capital and strategic guidance tailored to navigating regulatory landscapes and scaling responsibly.

For the UK startup ecosystem, Eka’s expanded war chest signals a deeper pool of patient capital ready to fund ambitious founders. Early‑stage founders can now tap into a fund that not only provides financial resources but also connects them to a network of impact‑aligned partners, from corporate pilots to ESG‑focused limited partners. As more investors benchmark success on both financial returns and societal outcomes, Eka’s model may become a template for future funds, accelerating the commercialization of innovations that improve health outcomes, reduce carbon footprints, and enhance overall wellbeing.